Expression and Genomic Configuration of GM-CSF, IL-3, M-CSF Receptor (C-FMS), Early Growth Response Gene-1 (EGR-1) and M-CSF Genes in Primary Myelodysplastic Syndromes

References

• Oscier D.G. Myelodysplastic syndromes. Clin. Haematol. 1987; 1: 389–426
   Google Scholar
• Heim S. Cytogenetic findings in primary and secondary MDS. Leuk. Res. 1992; 16: 43–46
   PubMed Web of Science ®Google Scholar
• Mufti G.J. Chromosomal deletions in the myelodysplastic syndrome. Leuk. Res. 1992; 16: 35–41
   PubMed Web of Science ®Google Scholar
• Heim S., Billstrom R., Kristofferson U., Mandahl N., Mitelman F. Late appearing 5Q marker in refractory anemia. Cancer Genet. Cytogenet. 1987; 24: 159–62
   PubMed Web of Science ®Google Scholar
• Le Beau M.M., Lemons R.S., Espinosal R., Larson R.A., Arai N., Rowley J.D. Interleukin-4 and in-terleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Blood 1989; 73: 647–650
   PubMed Web of Science ®Google Scholar
• Morris S.W., Valentine M.B., Shapiro D.N., Sublett J.E., Deaven L.L., Foust J.T., Roberts W.M., Cerretti D.P., Look A.T. Reassignment of the human CSF1 gene to chromosome Ip13-p21. Blood 1991; 78: 2013–2020
   PubMed Web of Science ®Google Scholar
• Willman C.L., Sever C.E., Pallavicini M.G., Harada H., Tanaka N., Slovak M.L., Yamamoto H., Harada K., Meeker T.C., List A.F., Taniguchi T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 1993; 259: 968–971
   PubMed Web of Science ®Google Scholar
• Bennet J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D. A. G., Gralnick H.R., Sultan C. Proposal for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982; 51: 189–190
   PubMed Web of Science ®Google Scholar
• Mareni C., Migeon B.R. Fragile x syndrome: Search for phenotypic manifestations at loci for hypoxanthine phosphoribosyltransfere and glucose-6-phosphate dehydrogenase. Am. J. Hum. Genet. 1981; 33: 752–761
   PubMed Web of Science ®Google Scholar
• Sessarego M., Ajmar F., Bianchi Scarra' G.L., Ravazzolo R., Garre C., Boccaccio P. Unusual Ph translocations in CML: Four new cases. Cancer Genet. Cytogenet. 1985; 15: 199–207
   PubMed Web of Science ®Google Scholar
• Maniatis T., Fritsch E., Sambrook J. Molecular cloning: A Laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1982
   Google Scholar
• Bianchi Scarra' G.L., Barresi R., Sessarego M., Ajmar F., Salvidio E. Marrow colony stimulating activity in chronic myelogenous leukemia. Exp. Hematol. 1981; 9: 917–925
   PubMed Web of Science ®Google Scholar
• Rambaldi A., Young D.C., Griffin J.D. Expression of the M-CSF (CSF-1) gene by human monocytes. Blood 1987; 69: 1409–1413
   PubMed Web of Science ®Google Scholar
• Wong G.G., Temple P.A., Leary A., Witek-Giannotti J.S., Yang Y., Ciarletta A.B., Chung M., Murtha P., Kritz R., Kaufman R.J., Ferenz C.R., Sibley B.S., Turner K.J., Hewick R.M., Clark S.C., Yanai N., Yokota H., Yamada M. Human CSF-1: Molecular cloning and expression of 4-kb cDNA encoding the human urinary protein. Science 1987; 235: 1504
   PubMed Web of Science ®Google Scholar
• Wong G.G., Witek J.A., Temple P.A., Wilkens K.M., Leary A.C., Luxenberg D.P., Jones S.S., Brown E.L., Kay R.M., Orr E.C., Shoemaker C., Golde D.W., Kaufman R.J., Hewick R.M., Wnag E.A., Clark S.C. Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 1985; 228: 810–814
   PubMed Web of Science ®Google Scholar
• Sukhatme V.P., Kartha S., Toback F.G., Taub R., Hoover R.G., Tsai-Morris C.H. A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res. 1987; 1: 343–355
   PubMedGoogle Scholar
• Hampe A., Gobet M., Sherr C.J., Galibert F. The nucleotide sequence of the feline retroviral oncogene v-fms shows unexpected homology with oncogenes encoding tyrosine pecific protein kinases. Proc. Natl. Acad. Sci. USA 1984; 81: 58–89
   Web of Science ®Google Scholar
• Yang Y.C., Ciarletta A.B., Temple P.A., Chung M.P., Kovacic S., Witek-Giannotti J.S., Leary A.C., Kriz R., Donahue R.E., Wong G.G., Clark S.C. Human IL-3 (Multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 1986; 47: 3–10
   PubMed Web of Science ®Google Scholar
• Kost T.A., Theodorakis N., Hughes S.H. The nucleotide sequence of the click cytoplasmic beta-actin gene. NAR 1983; 11(23)8287–8301
   PubMed Web of Science ®Google Scholar
• Rambaldi A., Wakamiya N., Vellenga E., Horiguchi J., Warren M.K., Kufe D., Griffin J.D. Expression of the macrophage colony-stimulating factor and c-fms genes in human acute myeloblasts leukemia cells. J. Clin. Invest. 1988; 81: 1030–1035
   PubMed Web of Science ®Google Scholar
• Nguyen H.Q., Hoffman-Liebermann B., Liebermann D.A. The zinc finger transcription factor Egrl is essential for and restricts differentiation along the macrophage lineage. Cell 1993; 72: 197–209
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek A., Belch A.R., Jacobs A., Bowen D., Padua R.A., Paietta E., Stanley E.R. Increased circulating colony-stimulating factor 1 in patients with preleukemia, leukemia and lymphoid malignancies. Blood 1991; 77: 1796–1803
   PubMed Web of Science ®Google Scholar
• Neuman W.L., Rubin C.M., Rios R.B., Larson R.A., Le Beau M.M., Rowley J.D., Vardiman J.W., Schwartz J.L., Farber R.A. Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders. Blood 1992; 79: 1501–1510
   PubMed Web of Science ®Google Scholar
• Le Beau M.M., Westbrook C.A., Diaz M.O., Larson R.A., Rowley J.D., Gasson J.C., Golde D.W., Sherr C.J. Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. Science 1986; 231: 984–987
   PubMed Web of Science ®Google Scholar
• Le Beau M.M., Epstein N.D., O'Brien S.J., Nienhuis A.W., Yang Y.C., Clark S.C., Rowley J.D. The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q. Proc. Natl. Acad. Sci. USA 1987; 84: 5913–5917
   PubMed Web of Science ®Google Scholar